Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter

Promising treatments for neurogenerative disorders may involve targeting kinetic intermediates, including α-synuclein oligomers. Here a kinetic method for quantifying oligomer populations is used to screen small molecule inhibitors of oligomerisation and gain mechanistic insight into their modes of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roxine Staats, Thomas C. T. Michaels, Patrick Flagmeier, Sean Chia, Robert I. Horne, Johnny Habchi, Sara Linse, Tuomas P. J. Knowles, Christopher M. Dobson, Michele Vendruscolo
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
Accès en ligne:https://doaj.org/article/25cc20ef6fa54796a866e8e34065ca87
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:25cc20ef6fa54796a866e8e34065ca87
record_format dspace
spelling oai:doaj.org-article:25cc20ef6fa54796a866e8e34065ca872021-12-02T12:41:24ZScreening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter10.1038/s42004-020-00412-y2399-3669https://doaj.org/article/25cc20ef6fa54796a866e8e34065ca872020-12-01T00:00:00Zhttps://doi.org/10.1038/s42004-020-00412-yhttps://doaj.org/toc/2399-3669Promising treatments for neurogenerative disorders may involve targeting kinetic intermediates, including α-synuclein oligomers. Here a kinetic method for quantifying oligomer populations is used to screen small molecule inhibitors of oligomerisation and gain mechanistic insight into their modes of action.Roxine StaatsThomas C. T. MichaelsPatrick FlagmeierSean ChiaRobert I. HorneJohnny HabchiSara LinseTuomas P. J. KnowlesChristopher M. DobsonMichele VendruscoloNature PortfolioarticleChemistryQD1-999ENCommunications Chemistry, Vol 3, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Chemistry
QD1-999
spellingShingle Chemistry
QD1-999
Roxine Staats
Thomas C. T. Michaels
Patrick Flagmeier
Sean Chia
Robert I. Horne
Johnny Habchi
Sara Linse
Tuomas P. J. Knowles
Christopher M. Dobson
Michele Vendruscolo
Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
description Promising treatments for neurogenerative disorders may involve targeting kinetic intermediates, including α-synuclein oligomers. Here a kinetic method for quantifying oligomer populations is used to screen small molecule inhibitors of oligomerisation and gain mechanistic insight into their modes of action.
format article
author Roxine Staats
Thomas C. T. Michaels
Patrick Flagmeier
Sean Chia
Robert I. Horne
Johnny Habchi
Sara Linse
Tuomas P. J. Knowles
Christopher M. Dobson
Michele Vendruscolo
author_facet Roxine Staats
Thomas C. T. Michaels
Patrick Flagmeier
Sean Chia
Robert I. Horne
Johnny Habchi
Sara Linse
Tuomas P. J. Knowles
Christopher M. Dobson
Michele Vendruscolo
author_sort Roxine Staats
title Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
title_short Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
title_full Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
title_fullStr Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
title_full_unstemmed Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
title_sort screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/25cc20ef6fa54796a866e8e34065ca87
work_keys_str_mv AT roxinestaats screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT thomasctmichaels screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT patrickflagmeier screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT seanchia screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT robertihorne screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT johnnyhabchi screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT saralinse screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT tuomaspjknowles screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT christophermdobson screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
AT michelevendruscolo screeningofsmallmoleculesusingtheinhibitionofoligomerformationinasynucleinaggregationasaselectionparameter
_version_ 1718393672802762752